Skip to main content

Table 1 Indication for ECLS support comparing in house implantation (Home) vs. external implantations (Transport)

From: ECLS supported transport of ICU patients: does out-of -house implantation impact survival?

Indication for ECLS

all

Home

Transport

p

Total

978 (100)

733

243

 

Pneumonia

292 (30)

189 (26)

102 (42)

p < 0.001

Influenca A

48 (5)

30 (4)

18 (7)

p = 0.32

ARDS

425 (44)

286 (39)

138 (57)

p = < 0.001

Lungfibrosis

33 (3)

30 (4)

3 (1)

p = 0.038

Pulmonary hypertension

43 (4)

35 (5)

8 (3)

p = 0.216

Cystic fibrosis

29 (3)

25 (3)

4 (2)

p = 0.373

Lung embolia

50 (5)

39 (5)

11 (5)

p = 0.384

PMR/VSD/ASD

29 (3)

19 (3)

10 (4)

p = 0.160

Myocardial infarction (NSTEMI, STEMI)

118 (12)

83 (11)

35 (14)

p = 0.212

DCM

80 (8)

64 (9)

15 (6)

p = 0.224

Myocarditis

26 (3)

15 (2)

11 (5)

p = 0.062

Peripartum cardiomyopathy

5 (0.5)

2 (0.3)

3 (1)

p = 0.224

Polytrauma

21 (2)

13 (2)

8 (3)

p = 0.102

Sepsis

49 (5)

49 (7)

0

p < 0.001

post DLTX

30 (3)

30 (4)

0

p < 0.001

Postcardiectomie

2 (0.2)

2 (0.3)

1 (0.4)

p = 0.564

Burn

16 (2)

16 (2)

0

p = 0.410

Post HTX

20 (2)

20 (3)

4 (2)

p = 0.006

Cardiac failure after VAD

34 (4)

33 (5)

1 (0.4)

p = 0.001

Postcardiotomie

109 (11)

108 (15)

1 (0.4)

p < 0.001

Others

92 (9)

83 (11)

9 (4)

p < 0.001

  1. ARDS: acute respiratory distress syndrome, PMR: Papillary muscle rupture, VSD: ventricular septum defect, ASD: atrial septum defect